Sanofi (SNYNF) Return on Assets (2018 - 2026)

Sanofi (SNYNF) posted Return on Assets of 0.0% for Q1 2026, down 4.1% sequentially from 0.0% in Q4 2025, and little changed YoY from 0.0% in Q1 2025.

Sanofi (SNYNF) Return on Assets (2018 - 2026) Analysis & Trends

Sanofi (SNYNF) has 3 years of Return on Assets data on file, last reported at 0.0% in Q1 2026.

Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
Return on Assets slipped to 0.0% in Q1 2026 per SNYNF's latest filing, from 0.0% in the prior quarter.
The five-year high for Return on Assets was 0.0% in Q3 2025, with the low at 0.0% in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROA (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn	0.00%
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn	0.00%
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn	0.00%
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn	0.00%
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn	0.00%
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn	0.00%
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn	0.00%
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn	0.00%
9	Novartis Ag	113.45 Bn	113.67 Bn	-	-
10	Sanofi	-	-	9.49 Bn	0.00%

Download Data